Preferred Label : ChAdOx1 nCoV-19 Vaccine;

NCIt synonyms : SARS-CoV-2 Vaccine AZD1222; ChAdOx1 nCoV-19; AZD1222 SARS-CoV-2 Vaccine; Oxford-Astrazeneca Covid Vaccine; ChAdOx1-S;

NCIt related terms : AZD-1222; AstraZeneca COVID-19 Vaccine;

NCIt definition : A vaccine composed of a replication-deficient chimpanzee adenovirus, ChAdOx1, encoding the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike glycoprotein (SP), with potential immunomodulating and anti-viral activities. Upon administration, ChAdOx1 nCoV-19 expresses the SARS-CoV-2 SP, which induces a humoral and cell-mediated immune response against SARS-CoV-2. This may prevent SARS-CoV-2 infection and inhibit viral replication. SP, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus.;

UNII : B5S3K2V0G8;

CAS number : 2420395-83-9; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2420395-83-9 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Vaxzevria; Covishield;

Molecule name : AZD 1222; AZD-1222;

NCI Metathesaurus CUI : CL1406792;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3235868/fr/strategie-de-vaccination-contre-la-covid-19-place-du-covid-19-vaccine-astrazeneca
2021
false
false
false
France
pneumonia, viral
coronavirus infections
adult
aged
guidelines for drug use
vaccine potency
ChAdOx1 nCoV-19 Vaccine
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
vaccines, recombinant
adenoviruses, simian
spike glycoprotein, coronavirus
immunization, secondary
drug storage
public health guidelines
vaccination
vaccination
pandemics
viral vaccines
vaccines, synthetic
pneumonia, viral
coronavirus infections
pandemics
viral vaccines
coronavirus infections
COVID-19
COVID-19 Vaccines
COVID-19 Vaccines

---
https://www.cbip.be/fr/articles/3518?folia=3503
2021
false
false
false
Belgium
French
journal article
ChAdOx1 nCoV-19 Vaccine
vaccination
Tozinameran
vaccine potency
mRNA Vaccines
Tozinameran
BNT162 Vaccine
pneumonia, viral
coronavirus infections
pandemics
viral vaccines
coronavirus infections
viral vaccines
coronavirus infections
COVID-19
COVID-19 Vaccines
COVID-19 Vaccines
vaccines, synthetic
mRNA Vaccine

---
Nous contacter.
21/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.